Affinity Asset Advisors, LLC
CIK 0001773195 · NEW YORK, NY · Quarter end: 2026-06-30 · Filed on: 2026-08-13 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$2.21B
2026 Q2
Positions
113
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
39.4%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
ROIV
ROIVANT SCIENCES LTD
6.0%
03770N101
APOGEE THERAPEUTICS INC
5.9%
SYRE
SPYRE THERAPEUTICS INC
5.1%
XENE
XENON PHARMACEUTICALS INC
4.4%
ERAS
ERASCA INC
4.3%
INSM
INSMED INC
3.1%
PRAX
PRAXIS PRECISION MEDICINES I
2.8%
ALKS
ALKERMES PLC
2.7%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.